Qualys is trading at $189.64, down 4.28%, as a broader selloff followed hotter-than-expected core inflation, renewing interest-rate concerns and pressuring growth stocks.

  • Qualys announced TruRisk Eliminate 2.0 on October 14, but reporting does not establish that the product news caused the decline.
  • TD Cowen raised its price target to $200 from $170 on October 13 and kept a Hold rating; that earlier action does not explain today’s drop.
  • No direct company-specific catalyst has been verified.